Literature DB >> 29088954

Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury.

Aditya Vedantam1, Claudia S Robertson1, Shankar P Gopinath1.   

Abstract

OBJECTIVE Hypernatremia is independently associated with increased mortality in critically ill patients. Few studies have evaluated the impact of hypernatremia on early mortality in patients with severe traumatic brain injury (TBI) treated in a neurocritical care unit. METHODS A retrospective review of patients with severe TBI (admission Glasgow Coma Scale score ≤ 8) treated in a single neurocritical care unit between 1986 and 2012 was performed. Patients with at least 3 serum sodium values were selected for the study. Patients with diabetes insipidus and those with hypernatremia on admission were excluded. The highest serum sodium level during the hospital stay was recorded, and hypernatremia was classified as none (≤ 150 mEq/L), mild (151-155 mEq/L), moderate (156-160 mEq/L), and severe (> 160 mEq/L). Multivariate Cox regression analysis was performed to determine independent predictors of early mortality. RESULTS A total of 588 patients with severe TBI were studied. The median number of serum sodium measurements for patients in this study was 17 (range 3-190). No hypernatremia was seen in 371 patients (63.1%), mild hypernatremia in 77 patients (13.1%), moderate hypernatremia in 50 patients (8.5%), and severe hypernatremia in 90 patients (15.3%). Hypernatremia was detected within the 1st week of admission in 79.3% of patients (n = 172), with the majority of patients (46%) being diagnosed within 72 hours after admission. Acute kidney injury, defined as a rise in creatinine of ≥ 0.3 mg/dl, was observed in 162 patients (27.6%) and was significantly associated with the degree of hypernatremia (p < 0.001). At discharge, 148 patients (25.2%) had died. Hypernatremia was a significant independent predictor of mortality (hazard ratios for mild: 3.4, moderate: 4.4, and severe: 8.4; p < 0.001). Survival analysis showed significantly lower survival rates for patients with greater degrees of hypernatremia (log-rank test, p < 0.001). CONCLUSIONS Hypernatremia after admission in patients with severe TBI was independently associated with greater risk of early mortality. In addition to severe hypernatremia, mild and moderate hypernatremia were significantly associated with increased early mortality in patients with severe TBI.

Entities:  

Keywords:  GCS = Glasgow Coma Scale; HR = hazard ratio; TBI = traumatic brain injury; hypernatremia; mannitol; mortality; neurocritical care; severe traumatic brain injury

Mesh:

Year:  2017        PMID: 29088954     DOI: 10.3171/2017.7.FOCUS17418

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  10 in total

Review 1.  Posterior pituitary dysfunction following traumatic brain injury: review.

Authors:  Roxana Maria Tudor; Christopher J Thompson
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

2.  Resuscitation Strategies for Traumatic Brain Injury.

Authors:  Henry W Caplan; Charles S Cox
Journal:  Curr Surg Rep       Date:  2019-05-15

Review 3.  Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist.

Authors:  Kevin C J Yuen; Valerie Sharf; Elizabeth Smith; Minhwan Kim; Alissya S M Yuen; Paul R MacDonald
Journal:  Stroke Vasc Neurol       Date:  2021-12-30

4.  Determinants affecting the prognosis of decompressive craniectomy for traumatic brain injury.

Authors:  Haitao Jiang; Guangshan Hao; Rui Zhang; Qi Pang
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

5.  Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database.

Authors:  Markus Harboe Olsen; Marcus Møller; Stefano Romano; Jonas Andersson; Eric Mlodzinski; Nathan H Raines; Raphael Sherak; Anni Nørgaard Jeppesen
Journal:  Crit Care Explor       Date:  2020-12-16

6.  Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.

Authors:  Jorge Gabriel Ruiz-Sánchez; Ivan J Núñez-Gil; Martin Cuesta; Miguel A Rubio; Charbel Maroun-Eid; Ramón Arroyo-Espliguero; Rodolfo Romero; Victor Manuel Becerra-Muñoz; Aitor Uribarri; Gisela Feltes; Daniela Trabattoni; María Molina; Marcos García Aguado; Martino Pepe; Enrico Cerrato; Emilio Alfonso; Alex Fernando Castro Mejía; Sergio Raposeiras Roubin; Luis Buzón; Elvira Bondia; Francisco Marin; Javier López Pais; Mohammad Abumayyaleh; Fabrizio D'Ascenzo; Elisa Rondano; Jia Huang; Cristina Fernandez-Perez; Carlos Macaya; Paz de Miguel Novoa; Alfonso L Calle-Pascual; Vicente Estrada Perez; Isabelle Runkle
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

7.  Serum sodium on admission affects postoperative in-hospital mortality in acute aortic dissection patients.

Authors:  Pengfei Huang; Hongyan Wang; Dong Ma; Yongbo Zhao; Xiao Liu; Peng Su; Jinjin Zhang; Shuo Ma; Zhe Pan; Juexin Shi; Fangfang Hou; Nana Zhang; Xiaohui Zheng; Nan Liu; Ling Zhang
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

Review 8.  Traumatic Brain Injury-A Review of Intravenous Fluid Therapy.

Authors:  Armi Pigott; Elke Rudloff
Journal:  Front Vet Sci       Date:  2021-07-09

9.  Hyperchloremia, not Concomitant Hypernatremia, Independently Predicts Early Mortality in Critically Ill Moderate-Severe Traumatic Brain Injury Patients.

Authors:  Kristen L Ditch; Julie M Flahive; Ashley M West; Marcy L Osgood; Susanne Muehlschlegel
Journal:  Neurocrit Care       Date:  2020-10       Impact factor: 3.532

Review 10.  Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice.

Authors:  Shawniqua Williams Roberson; Mayur B Patel; Wojciech Dabrowski; E Wesley Ely; Cezary Pakulski; Katarzyna Kotfis
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.